Target intelligence / Profile preview

Recipient cell membrane and associated surface proteins

Molecular classification
Other, Membrane-associated proteins, Lipid bilayer, Receptor, Transporter, Ion channel
01

Overview

The recipient cell membrane and associated surface proteins represent the complex biological boundary and signaling interface of a target cell (Alberts et al., 2002). Composed of a phospholipid bilayer and a diverse array of embedded glycoproteins, receptors, and transporters, this structure regulates the entry of ions, nutrients, and therapeutic agents (Cooper, 2000). In the context of infectious diseases, the membrane serves as the site for viral attachment and fusion, mediated by specific host cell receptors such as ACE2 for SARS-CoV-2 or CD4 for HIV (Marsh & Helenius, 2006). For oncology and immunology, surface proteins act as critical docking sites for monoclonal antibodies and chimeric antigen receptor (CAR) T-cells. While the membrane itself is a fundamental cellular component, it is not a single therapeutic target but rather a collection of thousands of potential targets (StatPearls, 2023). Consequently, pharmacological interventions must be highly specific to individual surface proteins to avoid broad cellular toxicity and ensure therapeutic efficacy.

Other names
Plasma membraneCell surfaceHost cell membraneCytoplasmic membraneCellular boundary
02

Mechanism of action

Drugs targeting components of the recipient cell membrane typically act via receptor antagonism, inhibition of viral-cell fusion, or direct disruption of the lipid bilayer integrity (Marsh & Helenius, 2006; StatPearls, 2023).

03

Biological functions

Signal transductionCell adhesionSelective permeabilityEndocytosisExocytosisCell-to-cell communication
04

Disease associations

InfectionCancerInflammationAutoimmune disease
05

Safety considerations

Non-specific membrane disruptionOff-target binding to healthy cellsSystemic toxicity from membrane lysisImmunogenicity of surface-modified therapies
06

Interacting drugs

Enfuvirtide

6 more in the full profile.

07

Biomarkers

CD4CCR5ACE2HER2EGFRCD20

Beyond the preview

Go deeper on Recipient cell membrane and associated surface proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recipient cell membrane and associated surface proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call